-
Thursday, March 14, 2024
A clinical trial from Keck Medicine of USC aims to provide a surgical solution for patients with a form of advanced pancreatic cancer previously considered inoperable. Until now, pancreatic cancer treatment has been limited to chemotherapy and radiation because the pancreas is surrounded and filled with arteries that carry blood to the rest of... Read More »
-
Wednesday, March 13, 2024
According to a multidisciplinary study from USC, Medicare Part D plans have significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments. The results, published in Health Affairs, showed that the share of drug compounds that was... Read More »
-
Wednesday, March 13, 2024
To democratize access to lab-grown, organ-like structures known as organoids and other advanced stem cell and transcriptomic technologies, USC Stem Cell will launch the CIRM ASCEND Center, dedicated to “Advancing Stem Cell Education and Novel Discoveries.” Funded by a $3.95 million grant from the California Institute for Regenerative Medicine (CIRM), ASCEND joins a network of resource-sharing... Read More »
-
Tuesday, March 12, 2024
A new study from the Keck School of Medicine of USC shows that a substantial number of young people in the United States are using delta-8-THC, a psychoactive substance manufactured from hemp-derived cannabidiol. The findings, published in JAMA, have raised concern among public health experts. Delta-8-THC has only been on the... Read More »
-
Tuesday, March 5, 2024
On Feb. 25, eight alumni of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences — formerly the USC School of Pharmacy — were honored at an annual gala that celebrates former students who are now leaders in their field. Hundreds of people attended the 2024 awards presentation,... Read More »
-
Tuesday, March 5, 2024
In a yearly tradition, the University of Southern California has announced a small, select group of faculty to be named University Professors and Distinguished Professors. Of the seven selected, three are faculty members from the Keck School of Medicine of USC: Peter Kuhn, PhD, University Professor Ricky Bluthenthal, PhD, Distinguished... Read More »
-
Tuesday, March 5, 2024
Keck Medicine of USC is calling for staff nominations for the ninth annual USC Choi Family Awards for Excellence in Patient-Centered Care, which will be presented the evening of June 6. The awards were created when the Choi family estate made a generous gift to Keck Medicine’s Patient Experience Department... Read More »
-
Monday, March 4, 2024
J. Dominic Femino, MD, has joined Keck Medicine of USC as chief of musculoskeletal oncology, a USC Orthopaedic Surgery program. A former USC faculty member, Femino returns to Keck Medicine after spending 16 years as City of Hope National Medical Center’s chief of orthopaedic surgery. As chief of Keck Medicine’s... Read More »
-
Tuesday, February 27, 2024
On Tuesday, four researchers from the Keck School of Medicine of USC were named senior members by the National Academy of Inventors (NAI), a nonprofit member organization that supports inventors in higher education. Andrew MacKay, PhD, of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, was also... Read More »
-
Tuesday, February 27, 2024
With the designation of a multi-million-dollar estate gift that includes support for Keck School of Medicine of USC, Jim Berchtold and his late wife, Amy King Dundon-Berchtold, established one of the school’s most significant planned legacy gifts. A significant portion of the gift will establish the Howard A. Liebman, MD,... Read More »
-
Monday, February 26, 2024
Mika Taylor has been named Keck Medicine of USC’s chief of financial planning and analysis (CFPA), effective Feb. 26. The news was shared by Chief Financial Officer Chris Allen on Feb. 22. Taylor will report directly to Allen and oversee budgeting, data management and reporting, as well as financial analytics... Read More »